There is provided pharmaceutically-acceptable acid addition salts of compounds of formula (I), wherein R1 represents C1-2 alkyl substituted by one or more fluoro substituents; R2 represents C1-2 alkyl; and n rep
-
Page 72-74
(2008/06/13)
IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION
According to the present invention there is provided an immediate release pharmaceutical formulation comprising, as active ingredient, a compound of formula (I), wherein R1 represents C?1-2#191 alkyl substituted by one or more fluoro substituen
-
Page 71-73
(2010/02/04)
MODIFIED RELEASE PHARMACEUTICAL FORMULATION
A modified release pharmaceutical composition comprising, as active ingredient, a compound of formula (I), wherein R1 represents C?1-2#191 alkyl substituted by one or more fluoro substituents;R2 represents hydrogen, hydroxy, methoxy
-
Page 73-74
(2010/02/04)
More Articles about upstream products of 631917-22-1